Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry-Reference-Cited by-同舟云学术

Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

Published:2012-09 Issue:9 Volume:107 Page:1409-1422
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

Lichtenstein Gary R,Feagan Brian G,Cohen Russell D,Salzberg Bruce A,Diamond Robert H,Price Samiyeh,Langholff Wayne,Londhe Anil,Sandborn William J

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/ajg2012218.pdf

Reference24 articles.

1. Emerging prognostic markers to determine Crohns disease natural history and improve management strategies: a review of recent literature.;Lichtenstein;Gastroenterol Hepatol (NY),2010

2. How do patients with inflammatory bowel disease want their biological therapy administered?;Allen;BMC Gastroenterol,2010

3. Tumor necrosis factor- monoclonal antibodies in the treatment of inflammatory bowel disease: clinical practice pharmacology.;Lee;Gastroenterol Clin North Am,2010

4. Efficacy of TNF antagonists beyond one year in adult and pediatric inflammatory bowel diseases: a systematic review.;Oussalah;Curr Drug Targets,2010

5. What is the optimal therapy for Crohns disease: step-up or top-down?;Lin;Expert Rev Gastroenterol Hepatol,2010

Cited by 666 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mortality Trends in Inflammatory Bowel Disease by Age, Sex, and Race in the United States from 1999 to 2020;Inflammatory Bowel Diseases;2024-09-11

2. Combined Advanced Targeted Therapy in Inflammatory Bowel Diseases: An Extensive Update;Inflammatory Bowel Diseases;2024-08-29

3. Meta-analysis of the Therapeutic Impact of Cannabinoids in Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2024-08-28

4. Common Mistakes in Managing Patients with Inflammatory Bowel Disease;Journal of Clinical Medicine;2024-08-14

5. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08